Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
3,961.37
3,321.79
3,435.08
3,013.41
2,703.90
4,407.23
4,571.35
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
3,961.37
3,321.79
3,435.08
3,013.41
2,703.90
4,407.23
4,571.35
Raw Material Cost
1,170.19
1,127.14
1,076.49
957.87
1,028.93
1,154.21
1,056.51
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
17.70
17.87
12.94
10.88
18.11
16.16
6.49
Selling and Distribution Expenses
1,717.40
1,267.83
1,278.57
1,213.40
1,033.47
1,736.35
1,490.97
Other Expenses
36.47
35.85
48.72
31.61
31.68
67.39
37.51
Total Expenditure (Excl Depreciation)
3,269.95
2,771.34
2,855.18
2,498.28
2,397.31
3,580.62
2,929.04
Operating Profit (PBDIT) excl Other Income
691.4
550.4
579.9
515.1
306.6
826.5999999999999
1642.3
Other Income
126.91
165.60
182.79
303.94
88.34
97.79
69.50
Operating Profit (PBDIT)
1,207.31
1,093.08
1,104.56
1,126.11
659.96
1,172.09
1,899.47
Interest
17.70
17.87
12.94
10.88
18.11
16.16
6.49
Exceptional Items
-143.00
-42.55
-22.80
-129.25
-282.85
-10.99
-0.66
Gross Profit (PBDT)
2,791.18
2,194.64
2,358.58
2,055.55
1,674.97
3,253.02
3,514.84
Depreciation
408.95
375.44
349.03
324.42
263.94
246.63
181.31
Profit Before Tax
637.66
657.22
719.80
661.56
95.05
898.30
1,711.02
Tax
27.36
60.93
79.36
71.52
6.61
169.51
251.66
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
601.57
580.07
637.09
533.73
60.86
715.20
1,458.22
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
601.57
580.07
637.09
533.73
60.86
715.20
1,458.22
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
3.59
0.76
-2.73
-5.41
-10.73
-33.36
-3.64
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
605.16
580.83
634.37
528.32
50.13
681.84
1,454.58
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
8,712.15
8,018.99
7,940.88
8,033.73
5,508.33
6,489.46
6,658.21
Earnings per share (EPS)
0.54
0.53
0.58
0.5
0.06
0.69
1.39
Diluted Earnings per share
0.54
0.53
0.58
0.5
0.06
0.69
1.39
Operating Profit Margin (Excl OI)
16.95%
16.62%
16.67%
16.52%
11.38%
18.78%
36.07%
Gross Profit Margin
26.42%
31.09%
31.11%
32.72%
13.28%
25.98%
41.4%
PAT Margin
15.19%
17.46%
18.55%
17.71%
2.25%
16.23%
31.9%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2024 is 19.25% vs -3.30% in Dec 2023
Consolidate Net Profit
YoY Growth in year ended Dec 2024 is 4.20% vs -8.45% in Dec 2023
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2024 is 16.49% vs 0.62% in Dec 2023
Interest
YoY Growth in year ended Dec 2024 is -1.12% vs 38.76% in Dec 2023
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2024 has improved from Dec 2023
Compare Annual Results Of Shenzhen Salubris Pharmaceuticals Co., Ltd. With
Figures in Million
Consolidate Annual Results
Change(CNY)
Change(%)
Net Sales
3,961.37
0
3,961.37
Other Operating Income
0.00
0.00
0.00
Total Operating income
3,961.37
0
3,961.37
Raw Material Cost
1,170.19
0
1,170.19
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
17.70
0
17.70
Selling and Distribution Expenses
1,717.40
0
1,717.40
Other Expenses
36.47
0.00
36.47
Total Expenditure (Excl Depreciation)
3,269.95
0
3,269.95
Operating Profit (PBDIT) excl Other Income
691.41
0.00
691.41
Other Income
126.91
0
126.91
Operating Profit (PBDIT)
1,207.31
0
1,207.31
Interest
17.70
0
17.70
Exceptional Items
-143.00
0
-143.00
Gross Profit (PBDT)
2,791.18
0
2,791.18
Depreciation
408.95
0
408.95
Profit Before Tax
637.66
0
637.66
Tax
27.36
0
27.36
Provisions and contingencies
0
0
0.00
Profit After Tax
601.57
0
601.57
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
601.57
0
601.57
Share in Profit of Associates
0
0
0.00
Minority Interest
3.59
0
3.59
Other related items
0.00
0.00
0.00
Consolidated Net Profit
605.16
0
605.16
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
8,712.15
0
8,712.15
Earnings per share (EPS)
0.54
0
0.54
Diluted Earnings per share
0.54
0
0.54
Operating Profit Margin (Excl OI)
16.95%
0%
0.00
16.95%
Gross Profit Margin
26.42%
0%
0.00
26.42%
PAT Margin
15.19%
0%
0.00
15.19%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 396.14 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 19.25% vs -3.30% in Dec 2023
Annual - Consolidate Net Profit
Consolidate Net Profit 60.52 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 4.20% vs -8.45% in Dec 2023
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 108.04 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 16.49% vs 0.62% in Dec 2023
Annual - Interest
Interest 1.77 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is -1.12% vs 38.76% in Dec 2023
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 16.95%
in Dec 2024Figures in %
YoY Growth in year ended Dec 2024 has improved from Dec 2023






